AIPTO

AIPTO TechBio pioneers a groundbreaking patient avatar technology utilizing patient tumor explants and organoids to faithfully replicate in vivo tumor biology. Augmenting this innovation is a cutting-edge generative AI technology driven by unparalleled single-cell RNA sequencing data obtained from these patient avatars. By synergizing the power of patient avatars with advanced AI capabilities, AIPTO is positioned to revolutionize drug discovery and precision medicine for brain cancer patients, offering a transformative path towards improved treatment outcomes.